Identifying Anticipated Events of Future Clinical Trials by Leveraging Data from the Placebo Arms of Completed Trials

BACKGROUND: An important component of a systematic strategy for safety surveillance is prospective identification of anticipated serious adverse events (SAEs). Developing a structured approach to identify anticipated events and estimating their incidence can help align the safety strategy and the sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xiang-Lin, Kern, David M., Cepeda, M. Soledad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864837/
https://www.ncbi.nlm.nih.gov/pubmed/33165761
http://dx.doi.org/10.1007/s43441-020-00237-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864837/
https://www.ncbi.nlm.nih.gov/pubmed/33165761
http://dx.doi.org/10.1007/s43441-020-00237-w

Ejemplares similares